BioLineRx (BLRX) Posts Q1 Loss of 1c/Share

BioLineRx (NASDAQ: BLRX) reported Q1 EPS of ($0.01), $0.05 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

You May Also Be Interested In

• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• KT&G approves KRW 360 billion share buyback and retirement plan
• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance